See this page online at: http://www.biotechfocus.com/2010Issue5
 |
Sign up for your subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
A Perfect Setting: Ontario is ready to accept its place as a leader in life sciences
By Chris Rogers
As we rode the five floors up to the OICR (Ontario Institute for Cancer Research) offices it was easy to get excited. MaRS, the centre of Toronto’s research initiatives and arguably the heart of Ontario’s Innovation Agenda sped by, and the glass walled elevator rose up over the offices revealing the Ontario legislature, Queen’s Park and beyond that the bustling University of Toronto. |
|
Baycrest: A centre of excellence for innovation in aging
By Shawn Lawrence
Fully affiliated with the University of Toronto and located in Toronto, Baycrest is a centre that provides care and services to approximately 2,500 people a day through its geriatric heath care system. To any outsider, it looks like a large hospital. But a closer look reveals Baycrest as a place where world recognized cognitive neuroscientists and talented clinicians have created a dynamic venture research environment focused on brain health and successful aging. |
|
Reshaping brain theory
By Chris Rogers
Neuroscientist Randy MacIntosh is driving urgently needed innovation around brain health. |
|
Matters of the mind: An overview of Ontario's neuroscience excellence
By Linda Quattrin
If it were an infectious disease, the prevalence would qualify as a global epidemic. The constellation of neurological and psychiatric-related disorders – from Alzheimer’s to anxiety – touches fully one in three Canadian families, according to Neuroscience Canada. And the picture, as we know, is only getting greyer given the aging demographic in the developed world. |
|
OICR-Big Ideas-Big Business
By Frank Stonebanks
Big ideas - big business How OICR is helping Toronto become a global centre of excellence for innovative, early stage oncology development. The Toronto region is one of North America’s top four economic powerhouses, along with New York, Los Angeles and Chicago and is ranked third for biomedical/biotechnology. The Ontario Institute for Cancer Research is a new arrival on the scene but has quickly established a reputation as an agile, innovative player in the R&D commercialization sphere. |
|
Samuel Lunenfeld Research, advancing neuroscience research in Canada
By Karin Fleming
A leading centre for innovation, expertise, and discovery. How the Samuel Lunenfeld Research Institute of Mount Sinai Hospital is advancing neuroscience research in Canada. This year marks the 25th anniversary of the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, one of the world's top 10 centres in biomedical research, and Canada's gold standard for genetics research and molecular medicine. |
|
Ontario Innovation Hubs
Ontario Innovation Hubs
|
|
No longer under the sun BRCA gene patents held not patentable in the US
By Carmela DeLuca and Micheline Gravelle
On Monday March 29th, 2010, in a highly anticipated decision, the U.S. District Court of the Southern District of New York ruled in favour of the plaintiffs in Association of Molecular Pathology et al v. U.S. Patent and Trademark Office et al., No. 09-CIV-4515 (“BRCA”), granting partial summary judgment and finding the claims in several patents on BRCA1 and BRCA2 invalid for encompassing non-statutory subject matter. |
|
The extent of miscibility of Canadian universities and commercialization
By Ulrich Krull
The role of Canadian universities in commercialization continues to generate substantial debate, prompted by signals from government and industry about a need to directly contribution to economic competitiveness and prosperity. |
